BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/14/2024 8:48:08 AM | Browse: 179 | Download: 737
 |
Received |
|
2024-02-16 14:17 |
|
Peer-Review Started |
|
2024-02-16 14:17 |
|
First Decision by Editorial Office Director |
|
2024-03-05 20:02 |
|
Return for Revision |
|
2024-03-05 20:02 |
|
Revised |
|
2024-03-15 18:07 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-04-09 03:14 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-04-09 08:01 |
|
Articles in Press |
|
2024-04-09 08:01 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-05-08 06:57 |
|
Publish the Manuscript Online |
|
2024-05-14 08:48 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Cetuximab combined with chemotherapy for simultaneous esophageal squamous cell carcinoma and colon adenocarcinoma: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xin-Xin Luo, Yu-Xuan Du, Qi-Qing Zhang, Lin Zhang, Shu-Ying Zeng, Zhi-Hong Yu, Peng Shen and Zheng-Quan Feng |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Zheng-Quan Feng, MD, PhD, Chief Physician, Director, Director, Department of Oncology, Tongde Hospital of Zhejiang Province, No. 234 Gucui Road, Xihu District, Hangzhou 310012, Zhejiang Province, China. fzhq213@aliyun.com |
| Key Words |
Synchronous multiple primary carcinoma; Esophageal squamous cell carcinoma; Colon adenocarcinoma; Cetuximab; Chemotherapy; Case report |
| Core Tip |
We report a case of a 64-year-old patient diagnosed with synchronous esophageal squamous cell carcinoma and colon adenocarcinoma with liver metastasis. After multi-disciplinary consultations, oxaliplatin + capecitabine chemotherapy and esophageal cancer radiotherapy were initiated. Based on genetic testing, treatment was switched to a regimen of leucovorin + fluorouracil + oxaliplatin and cetuximab for 8 cycles. Subsequently, capecitabine and bevacizumab were administered, and the tumor was stable at the most recent follow-up. This case demonstrates successful treatment of dual primary digestive tract tumors of differing pathological types using the same regimen, which supports non-surgical, simultaneous treatment for synchronous multiple primary cancers. |
| Publish Date |
2024-05-14 08:48 |
| Citation |
Luo XX, Du YX, Zhang QQ, Zhang L, Zeng SY, Yu ZH, Shen P, Feng ZQ. Cetuximab combined with chemotherapy for simultaneous esophageal squamous cell carcinoma and colon adenocarcinoma: A case report. World J Clin Cases 2024; 12(15): 2649-2654 |
| URL |
https://www.wjgnet.com/2307-8960/full/v12/i15/2649.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v12.i15.2649 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
